Recombinant Immunotoxin Targeting Mesothelin Read more about Recombinant Immunotoxin Targeting Mesothelin EgyptPCT/NA/1697/2013Filed on 2013-11-06
Recombinant Immunotoxin Targeting Mesothelin Read more about Recombinant Immunotoxin Targeting Mesothelin EcuadorSP-13-13067Filed on 2012-05-04
Recombinant Immunotoxin Targeting Mesothelin Read more about Recombinant Immunotoxin Targeting Mesothelin Chile03182-2013Filed on 2012-05-04
Recombinant Immunotoxin Targeting Mesothelin Read more about Recombinant Immunotoxin Targeting Mesothelin Canada2835070Filed on 2012-05-04
Recombinant Immunotoxin Targeting Mesothelin Read more about Recombinant Immunotoxin Targeting Mesothelin Brazil112013028537-0Filed on 2012-05-04
Recombinant Immunotoxin Targeting Mesothelin Read more about Recombinant Immunotoxin Targeting Mesothelin Australia2012253896Filed on 2012-05-04
Engineered Antibody Constant Domain Molecules Read more about Engineered Antibody Constant Domain Molecules US Patent 9,527,903Filed on 2013-10-01
MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) Read more about MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) Spain07867402.5Filed on 2009-04-24
MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) Read more about MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) Germany07867402.5Filed on 2009-04-24
Lentivirus Expressing Mutant Forms On Human Thymidylate Monophosphate Kinase 9tmpk), F105Y Adn R16G Lid Read more about Lentivirus Expressing Mutant Forms On Human Thymidylate Monophosphate Kinase 9tmpk), F105Y Adn R16G Lid US Application 12/843,238Filed on 2010-07-26